The limited availability of monoclonal antibodies for the treatment of kidney diseases has long been a source of frustration for the nephrology community. However, the emergence of therapies targeting ...
Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the initiation of a Phase 2 basket ...
New playground, parking and pathways planned at Islanders Beach Park ...
GenPro has launched its election policy manifesto, Seven Steps to Restore General Practice, calling on all political parties ...
RG-6299 targets major unmet need in IgA nephropathy with a differentiated monthly antisense therapy. Promising clinical data, global Phase III development and strong partnerships support adoption, ...
Companies that place human learning at the center of innovation will help shape the next chapter of education—one where AI ...
The F-15EX Eagle II represents one of the most compelling arguments in modern military aviation: that a legacy airframe, ...
A team involving researchers from Wroclaw Medical University analyzed studies of people with schizophrenia spectrum disorders ...
Ammobia announced an agreement with Lummus Technology to license and deploy Ammobia’s ammonia production system. Through this ...
The program will offer an associate-degree milestone, paid-work opportunities, DART passes, meals and laptops.
Leo Cancer Care, a pioneer in upright radiation therapy, today announced a commercial collaboration with GE HealthCare, a ...
Housing, health care and child care costs are central issues in Delaware's District 5 Senate race.